Lymphoproliferative Erkrankungen.

Greil, R, 2006.

A role of TRAIL in killing osteoblasts by myeloma cells

Tinhofer, I, Biedermann, R, Krismer, M, Crazzolara, R, Greil, R FASEB J. 2006 Apr,20(6):759-61. Epub 2006 Jan 25.

The still long and winding road to neoadjuvant sytemic therapy as the standard of care in breast cancer

Greil, R BREAST CARE. 2006, 1(6): 352-357.

Clinical practice aromatase inhibitors: Upfront, switch or extended?

Greil, R, Jonat, W, Maass, N, Kaufmann, M, Ortmann, O, Possinger, K, Steger, G BREAST CARE. 2006, 1(1): 37-43.

Adjuvant treatment with trastuzumab in clinical practice outside clinical studies

Senn, HJ, Thurlimann, B, von Minckwitz, G, Herrmann, R, Jakesz, R, Gnant, M, Greil, R BREAST CARE. 2006, 1(2): 96-101.

A role of TRAIL in killing osteoblasts by myeloma cells.

Tinhofer I, Biedermann R, Krismer M, Crazzolara R, Greil R. FASEB J. 2006 Apr,20(6):759-61. Epub 2006 Jan 25.

Diffuse large B-cell lymphoma as a second, clonally unrelated lymphoproliferative disease in a patient with IgM monoclonal gammopathy of undetermined significance (MGUS) and concomitant polycythemia vera rubra.

Mian M, Psenak O, Greil R, Fiegl M, Tzankov A. Leuk Lymphoma. 2006 May,47(5):940-3. No abstract available.

[Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms].

Hilbe W, Aigner K, Dittrich C, Eckmayr J, Fiegl M, Flicker M, Forstner B, Greil R, Jamnig H, Krajnik G, Lang A, Mohn-Staudner A, Schinko H, Studnicka M, Pirker R, Ploner F, Rothmund J, Schiller L, Zabernigg A, Zöchbauer-Müller S. Wien Klin Wochenschr. 2007,119(7-8):259-66.

Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.

Steger GG, Galid A, Gnant M, Mlineritsch B, Lang A, Tausch C, Rudas M, Greil R, Wenzel C, Singer CF, Haid A, Pöstlberger S, Samonigg H, Luschin-Ebengreuth G, Kwasny W, Klug E, Kubista E, Menzel C, Jakesz R J Clin Oncol. 2007 May 20,25(15):2012-8.

Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group.

Porschen R, Arkenau HT, Kubicka S, Greil R, Seufferlein T, Freier W, Kretzschmar A, Graeven U, Grothey A, Hinke A, Schmiegel W, Schmoll HJ J Clin Oncol. 2007 Sep 20,25(27):4217-23. Epub 2007 Jun 4.